Cannabis
CANNTAB SIGNS TERM SHEET WITH HERITAGE FOR PROCESSING HEMP FOR SALE OF CBD FILLED GELCAPS
– Canntab Makes Progress Towards Becoming Revenue-Generating in 2019 –
[…]
Articles by The Wall Street Analyzer
News Feed
Clear Blue Technologies Launches Energy-as-a-Service for Wireless Power
TORONTO, May 22, 2019 (GLOBE NEWSWIRE) — Clear Blue Technologies International Inc. (“Clear Blue” or “the Company”) (TSXV:CBLU) (FRANKFURT:0YA) announced today the launch of its Energy-as-a-Service (EaaS) for wireless power. This new subscription-based service provides […]
Cannabis
Canntab Receives Cultivation Licence for Industrial Hemp
Enables Canntab to Leverage Properties in Saskatchewan and Ontario to Cultivate High Quality Hemp for the Extraction of Cannabidiol (CBD) Additionally, Canntab’s application is currently “In Progress” to obtain a Cannabis Licence (Processing- Standard, Federal […]
Biotech
EastGate Biotech Announces Preparation to Initiate Phase III Clinical Trials on Insugin, its Liquid Insulin Mouth Rinse for Type 2 diabetes patients
Multi-Center Phase III trial planned for 2019
[…]
Healthcare
Soligenix Announces Recent Accomplishments And First Quarter 2019 Financial Results
PRINCETON, NJ – May 14, 2019 – Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical […]
Technology
Earth Alive Clean Technologies (CSE:EAC) (OTC: EACTF) has positioned itself to provide sustainable solutions to the agricultural and industrial markets
Key Company Highlights:*Providing Agricultural and Cultivation Solutions to Farmers*Infrastructure Maintenance and Cleaning Solutions to Mining sector*Preventing Water Contamination*Retail Opportunities INTERVIEW TRANSCRIPTS: WSA: Good day from Wall Street this is Juan Costello, Senior Analyst with the […]
Healthcare
Soligenix, Inc (NASDAQ: SNGX) CEO Dr. Chris Schaber talks about their two Phase III trials and upcoming interim analysis
INTERVIEW HIGHLIGHTS: *Two Pivotal Phase III studies for T-cell Lymphoma and Oral mucositis *Enrollment milestone for SGX942 *Upcoming interim analysis for SGX942 in September *Top-line final results for CTCL expected in 1Q 2020 INTERVIEW SUMMARY: […]
Biotech
Anna Gluskin, CEO of Eastgate BioTech (OTC: ETBI) discusses positive results and how they are ready to take the Insulin market by storm.
“We’re doing a number of trials in Pakistan right now and the results that we announced just the other day; the end of the month, we’re showing a very good efficacy in absorption of product without injection.” […]
CEO Interviews
Eagle Graphite Incorporated (TSXV: EGA) Interview with Jamie Deith, President & CEO
THIS INTERVIEW HAS EXPIRED